Skip to main content

IQ Capital — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

202
Companies
$1.4B
Total invested
$17.1M
Avg. check
52
Industries
Artificial Intelligence (AI) 7Software 6Biotechnology 5Cyber Security 4Machine Learning 4Manufacturing 3+46 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 202
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
IONATE
February 2025

IONATE creates energy solutions with hybrid intelligent transformers and AI-driven grid management for a more efficient power system.

Electrical Distribution · Edinburgh$17.0M Series A
Mindgard
December 2024

Mindgard empowers enterprise security teams to deploy AI and GenAI securely.

Artificial Intelligence (AI) · London$8.2M Venture - Series Unknown
Planetary
October 2024

Planetary does coastal carbon removal through ocean alkalinity enhancement.

Chemical · Dartmouth$11.3M Series A
webAI
September 2024

The leader in private AI.

Artificial Intelligence (AI) · Austin$43.0M Series A
NanoSyrinx
September 2024

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.

Biotechnology · Coventry$13.1M Series A
Oxford Space Systems
May 2024

OSS Is a space technology business that provides multi-award winning deployable antennas & structures made from proprietary materials.

Aerospace · Harwell$4.0M Venture - Series Unknown
Baseimmune
February 2024

Baseimmune is a biotech startup founded to create the next generation of vaccines.

Biotechnology · London$11.4M Series A
Trogenix
January 2024

Trogenix operates as a therapeutics company.

Health Care · Edinburgh$19.1M Seed
Mytos
November 2023

Mytos is building a fully-automated cell manufacture platform for Pharma

Biotechnology · London$19.0M Series A
Bmll Technologies
September 2023

BMLL Technologies is the top independent source for Level 3 Historical Data and Analytics catering to participants in the Capital Markets.

Analytics · London$10.5M Seed
Mindgard Ltd
September 2023

Mindgard Ltd provides AI security solutions, detecting and mitigating cyber threats for enterprise AI models.

Artificial Intelligence (AI) · London$3.8M Seed
Signaloid
May 2023

Signaloid is a cloud-based computing platform.

Artificial Intelligence (AI) · Cambridge$3.7M Seed
Funderbeam
May 2023

Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes.

Big Data · London$40.0M Venture - Series Unknown
CyberSmart
February 2023

An all-in-one cybersecurity monitoring, optimisation, training and insurance platform proven to defend SMBs against the unexpected.

B2B · London$15.3M Series B
Apperio
January 2023

Apperio is a legal spend management software that helps in-house legal teams stay control their spend and build trust with external counsel.

Legal Tech · London$7.0M Venture - Series Unknown
eCargo Enterprise Limited
January 2024

eCargo Enterprise, an e-commerce enabler, provides holistic solutions to designer brands, retailers, and branded manufacturers in China.

Business Development · Tsuen Wan$5.0M Post-IPO Debt
Swap
January 2026

Swap Commerce provides an e-commerce operating system that helps online brands unify and manage their commerce operations.

E-Commerce · London$100.0M Series C
Perfect Day
January 2024

Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk.

Bakery · Berkeley$90.0M Series E
SalioGen Therapeutics
January 2022

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Biotechnology · Burlington$115.0M Series B
Hometap
December 2025

Hometap is a fintech company allowing homeowners to tap their home equity without monthly payments.

Finance · Boston$50.0M Private Equity
Outtake
January 2026

Outtake is a digital trust platform automating threat classification, detection, and response to enhance enterprise cybersecurity measures.

Artificial Intelligence (AI) · Brooklyn$40.0M Series B
causaLens
January 2022

Digital Workers enterprises can truly rely on.

Artificial Intelligence (AI) · London$44.9M Series A
Standard Template Labs
March 2026

ST Labs is an AI service management platform handling requests and incidents to reduce manual coordination required to deliver IT services.

Artificial Intelligence (AI) · New York$49.0M Seed

Where IQ Capital invests

Artificial Intelligence (AI)7
Software6
Biotechnology5
Cyber Security4
Machine Learning4
Manufacturing3

About IQ Capital's portfolio

How many companies has IQ Capital invested in?

IQ Capital has invested in 202 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does IQ Capital invest in?

IQ Capital's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Cyber Security, Machine Learning. The firm invests across 52 different industry categories.

What is IQ Capital's largest investment?

Among tracked funding rounds, SalioGen Therapeutics received $115.0M in a Series B round. IQ Capital's total known invested capital is $1.4B.

What is the average investment size for IQ Capital?

IQ Capital's average investment size is $17.1M across its portfolio of 202 companies.

What are IQ Capital's most recent investments?

Recent IQ Capital portfolio additions include Cambridge GaN Devices, IONATE, Mindgard, Planetary, webAI. These companies were founded in 2020 or later.

Reach the founders behind these 202 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →